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OBJECTIVE: To analyze the prenatal outcomes in a cohort of fetuses with mild bilateral pyelectasis and
determine whether performing serial ultrasounds is a good follow-up strategy.
METHODS: A prospective longitudinal study was conducted on 62 fetuses with mild bilateral pyelectasis. Fetal
mild bilateral pyelectasis was considered when the renal pelvis measured (in millimeters)X5.0 to 10.0,X7.0 to
10.0, and X10.0 to 15 at p23 weeks 6 days, 24 to 31 weeks 6 days, and X32 weeks, respectively, with no
uretero-calyceal dilatation. Ultrasounds were performed every 3 weeks to assess whether the mild bilateral
pyelectasis regressed, remained unchanged (Group 1) or progressed (Group 2).
RESULTS: Group 1 consisted of 53 fetuses (85.4%), and progression was observed in 9 cases (Group 2, 14.6%).
The initial renal pelvis diameter was significantly larger in fetuses with progression (p=0.028). Statistically
significant differences in the renal pelvis diameter were also found at weeks 31 and 35 for both kidneys
(po0.05). The cases requiring intrauterine procedures or early delivery were not observed.
CONCLUSION: Fetal mild bilateral pyelectasis with no calyceal dilatation is a benign condition that can be
managed in the postnatal period. The initial renal pelvis diameter and the diameter in week 31 or 35 were
valuable parameters for identifying cases that would eventually need specific postnatal procedures.
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’ INTRODUCTION
Pyelectasys (PE), i.e., a dilatation exclusively involving the
fetal renal pelvis, is a common ultrasonographic finding that
is identified in 1-5% of fetuses in the second and third tri-
mesters of pregnancy (1-8). Various criteria are used to define
renal pelvis dilatation. The cut-off limits for defining mild
pyelectasis also vary (9-12). Many of these cases are sent to
referral centers and subjected to serial scans; however, these
interventions do not have a significant impact on prognosis,
in accordance with the literature, which characterizes PE
as regressive with self-limiting lesions (11-18). However,
in some cases, lesions can progress and become an issue in
perinatal care.
Identifying PE cases that can progress to medium or severe
dilatation with hydronephrosis, characterized by an altered
amount of amniotic fluid and possible renal function impair-
ment, is important for determining appropriate perinatal
care strategies. Thus, knowing the natural prenatal history
and identifying eventual progression factors of FMBP cases
are of great interest because serial ultrasound scanning can
lead to unnecessary expenses and anxiety. A better under-
standing of FMBP could also eliminate the dissemination
of equivocal information to parents and provide them with
better support (5,19-21). However, in cases with potential
renal disease, it is possible to perform a suitable diagnostic
or therapeutic intervention and prevent kidney function
damage (22-24).
Therefore, the aims of this study were to analyze the pre-
natal outcomes in a cohort of fetuses with mild bilateral
pyelectasis (FMBP) and determine whether performing serial
ultrasounds (USs) is a good follow-up strategy.
’ MATERIALS AND METHODS
A prospective study of a cohort of fetuses with FMBP
referred to our center was carried out between June 2011 and
December 2012 at the Fetal Medicine Unit at São Paulo
University Medical School Hospital, Brazil.
FMBP was defined by an RP diameter of X5.0 mm and
o10.0 mm until 23 w 6 d;X7.0 mm ando10.0 mm between
24 w and 31 w 6 d; and X10.0 mm and o15.0 mm from
32 w gestational age (GA) with no uretero-calyceal dilatation
(25-29).DOI: 10.6061/clinics/2016(09)05
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The inclusion criteria were singleton pregnancies with
FMBP according to the above criteria, absence of calyceal
dilatation, and absence of ultrasonographic signs of lower
urinary tract obstruction, i.e., absence of urethral and/or
bladder dilatation at the time of pyelectasis diagnosis.
The exclusion criteria were less than three USs performed
at our center, diabetic patients, macrosomic fetuses (fetal weight
over the 90th percentile) or intrauterine growth-restricted
fetuses (estimated fetal weight under the 10th percentile) (30),
fetal chromosomal defects, fetal death during follow-up, and
the presence of other fetal structural abnormalities.
Cardiac defects and other structural malformations were
ruled out with a fetal structural ultrasound and echocardio-
graphy.
Ultrasound examinations were performed every three weeks.
The serial assessments of the fetal renal pelvis were performed
by measuring the anteroposterior diameter of each renal pelvis
in millimeters to one decimal in a strict transverse view of the
fetal abdomen at the level of the renal pelvis, preferably with
the spine in the anterior position, and by the visualization of
symmetric lateral ossification centers. The presence or absence
of visible calyceal groups was confirmed by coronal US views
of the kidneys at the level of the renal pelvis.
Natural history
For the entire cohort of fetuses, multiple Bonferroni com-
parisons (31) between the diameters until the 24th week and
the RP diameters obtained after the 24th week (on a week-
by-week basis) were performed to determine the natural
evolution of RP diameters over subsequent weeks compared
with the diameters in earlier weeks (gestational age when
fetal structural US is routinely performed). The left and right
kidneys were analyzed separately.
The first and last assessments of RP diameters were then
compared with the RP diameters of the entire population using
paired Student’s t tests (32) to assess the natural history of FMBP.
Progression, stability, and regression analysis
FMBP progression, regression, and stability were defined
as follows.
 Regression: measurements returning to the normal range
for the corresponding gestational age.
 Progression: fetal renal pelvic diameter becoming greater
than the reference values for at least one kidney ?? or the
presence of calyceal dilatation.
 Stability: RP diameter being maintained at the same level
according to gestational age for at least one kidney.
Based on the last prenatal US examination, the cases were
divided into two groups: regression and stability (Group 1)
and progression (Group 2). The results were compared
between groups.
Maternal characteristics (age and parity), initial RP dia-
meter, GA at diagnosis, and fetal gender were also assessed
and compared between groups (mean, standard deviation,
median, minimum, and maximum) using Student’s t test or
the Mann-Whitney U test and chi-square test (fetal gender) to
determine whether any of these variables could distinguish
between the different groups.
’ ETHICS
This study followed the tenets of the Declaration of
Helsinki and the rules of Resolution No. 196/96 of the
Brazilian National Health Council. All patients were infor-
med about the research objectives. Only those who volunta-




A total of 62 fetuses met the inclusion criteria and had a
complete set of follow-up USs during the prenatal period.
Initially, 73 cases were included in the analysis. However,
11 patients were excluded for the following reasons: missed
follow-up in 7 cases, chromosomal abnormalities in 2 cases
(T21), and gestational diabetes in 2 cases.
The fetuses population consisted of 47 males and 15 females
(3.1:1). The gestational age at diagnosis ranged from 19.2 to
30.1 weeks (mean 23.2 weeks). The total number of US
examinations was between 3 and 7 (mean 4.5).
The maternal age ranged from 15 to 44 years (mean 28.1
years). The parity ranged between 1 and 10 pregnancies
(mean 2.1 pregnancies).
Natural History
There was a significant difference in the mean RP diameter
between the gestational weeks in both kidneys (po0.001)
(Figure 1).
Although the RP diameters increased in the remaining
weeks of pregnancy compared with the first weeks (19 to
24 weeks), the only statistically significant differences were
in gestational weeks 31 and 35 for both kidneys (po0.05).
However, these differences were not maintained every week
or after a certain gestational age (p40.05) (Table 1).
For both kidneys, there was a statistically significant
average increase in the RP diameters from the first to the
last assessment (p=0.001 and po0.001, respectively), with the
first evaluation performed between 19 and 30 weeks of
pregnancy and the last assessment performed between
30 and 40 weeks gestation (Table 2).
The volume of amniotic fluid remained normal in the
ultrasound evaluations in all the cases.
Groups
During the prenatal period, pyelectasis regression occur-
red in 29 cases (46.7%), i.e., there was a normalization of the
RP without calyceal dilatation. In 24 cases (38.7%), dilatation
of the RP remained stable (pyelectais remained in at least
one kidney). Stability and regression (Group 1) occurred in
53 cases (85.4%).
Unilateral progression (Group 2) was observed in 9 cases
(14.6%). Severe cases, i.e., cases that required intrauterine
procedures or early delivery, were not observed in this
cohort.
The only statistically significant difference between the
groups was the initial RP diameter of the right kidney, which
was, on average, larger in the fetuses in Group 2 (p=0.028).
Although not statistically significant, there was a bigger
initial diameter of the left kidney pelvis in the Group 2
fetuses (p=0.116) (Table 3).
Maternal age, parity, gestational age at diagnosis, and fetal
gender were not significantly different between the groups.
PERINATAL RESULTS
Thirty-two newborns (NBs) in this prenatal cohort were exam-
ined. Only the first postnatal US was considered in the analysis.
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Figure 1 - Mean profiles and standard errors of the RP diameters according to gestational age.
Table 1 - Results of multiple Bonferroni comparisons of the renal pelvic diameters before 25 weeks gestation with those in the other
weeks.
Kidney Comparison Mean Difference Standard Error df p
CI (95%)
Lower Upper
Right 19 to 24 weeks - 25 weeks 0.31 0.58 1 40.999 -1.73 2.35
19 to 24 weeks - 26 weeks -0.18 0.47 1 40.999 -1.85 1.50
19 to 24 weeks - 27 weeks -0.18 0.51 1 40.999 -1.96 1.60
19 to 24 weeks - 28 weeks -1.06 0.57 1 40.999 -3.07 0.95
19 to 24 weeks - 29 weeks -0.02 0.53 1 40.999 -1.89 1.86
19 to 24 weeks - 30 weeks -0.20 0.52 1 40.999 -2.05 1.65
19 to 24 weeks - 31 weeks -2.72 0.59 1 o0.001 -4.80 -0.65
19 to 24 weeks - 32 weeks -0.50 0.57 1 40.999 -2.53 1.53
19 to 24 weeks - 33 weeks -1.10 0.56 1 40.999 -3.07 0.87
19 to 24 weeks - 34 weeks -0.46 0.62 1 40.999 -2.65 1.74
19 to 24 weeks - 35 weeks -2.29 0.58 1 0.009 -4.34 -0.24
19 to 24 weeks - 36 weeks -2.35 0.67 1 0.059 -4.72 0.03
19 to 24 weeks - 37 weeks -1.80 0.60 1 0.331 -3.93 0.32
19 to 24 weeks - 38 weeks -2.78 0.89 1 0.222 -5.94 0.37
19 to 24 weeks - 39 weeks -1.18 1.27 1 40.999 -5.66 3.30
Left 19 to 24 weeks - 25 weeks -0.68 0.69 1 40.999 -3.12 1.75
19 to 24 weeks - 26 weeks -1.15 0.56 1 40.999 -3.14 0.85
19 to 24 weeks - 27 weeks -1.41 0.60 1 40.999 -3.53 0.72
19 to 24 weeks - 28 weeks -1.55 0.68 1 40.999 -3.95 0.85
19 to 24 weeks - 29 weeks -1.08 0.64 1 40.999 -3.33 1.17
19 to 24 weeks - 30 weeks -1.49 0.63 1 40.999 -3.72 0.73
19 to 24 weeks - 31 weeks -2.57 0.71 1 0.032 -5.07 -0.08
19 to 24 weeks - 32 weeks -1.79 0.69 1 40.999 -4.23 0.64
19 to 24 weeks - 33 weeks -2.90 0.67 1 0.002 -5.28 -0.52
19 to 24 weeks - 34 weeks -2.64 0.75 1 0.056 -5.30 0.02
19 to 24 weeks - 35 weeks -3.60 0.71 1 o0.001 -6.09 -1.11
19 to 24 weeks - 36 weeks -2.73 0.82 1 0.113 -5.64 0.18
19 to 24 weeks - 37 weeks -3.34 0.74 1 0.001 -5.96 -0.71
19 to 24 weeks - 38 weeks -3.64 1.10 1 0.109 -7.51 0.23
19 to 24 weeks - 39 weeks -2.02 1.55 1 40.999 -7.48 3.44
Results of multiple Bonferroni comparisons.
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The NB age at the time of ultrasound varied from 4 to 20 days
(mean 7.3 days).
Twenty-six NBs were in the regression or stability prena-
tal group. Twenty had normal kidneys at the postnatal
ultrasound. Six showed persistent mild pyelectasis, with
no clinical consequences to date. Six NBs were in Group 2,
three of whom had no clinical events and three of whom
were followed in the nephro-urologic unit. The NB analysis
results were not discordant with the Group 1 or 2 prenatally
classified fetuses.
’ DISCUSSION
The goal of this study was to assess the natural history of
FMBP and to investigate whether serial US scans are needed
in cases of isolated pyelectasis without calyceal dilatation.
This series consisted of a prospective study in a cohort of
fetuses with MBPE with rigorous inclusion criteria; i.e., only
bilateral pyelectasis cases with no calyceal dilatation were
included.
The study results showed that the RP diameters in the
cases of FMBP increased in late pregnancy compared
with the second trimester. The differences were statistically
significant for both kidneys in gestational weeks 31 and 35.
An increase in the RP diameters from the first to the last
assessment was also demonstrated. This observation is
similar to results in the literature. The relationship of the RP
diameter with postnatal prognosis has also been confirmed
(5,13,21,27,33-35).
After the initial analysis, the cases were divided into
two groups: the stable or regression group (85.4%) and the
progression group (14.6%). The literature has shown that the
outcomes are essentially benign. More than 85% of RP dila-
tation cases remain stable or regressed (9,20,26,27,33,36,37).
In the present series, even in cases in which progression was
observed, there were no severe cases, i.e., no cases requiring
early delivery or invasive intrauterine procedures. Addition-
ally, no changes in amniotic fluid levels were observed.
Repeating US scans every three weeks did not show any
benefit in our study because no intervention was indicated in
the prenatal period.
Although the number of cases in Group 2 was not large,
some findings were of interest when we compared the groups.
For example, the initial pelvic diameter was significantly
higher in Group 2 (for the right kidney). This result suggests
that the higher the RP diameter at the time of diagnosis, the
greater the possibility that the renal pelvis will remain dilated
during pregnancy, which is consistent with the literature
(21,34,38).
Based on the natural history obtained in the present study,
the diameters of the renal pelvis increased in late pregnancy
compared with the weeks in which the structural fetal ultra-
sound was performed (19 to 24 weeks), reaching a statisti-
cally significant difference in gestational weeks 31 and 35.
Table 2 - The first and last diameters of the renal pelvis and results of the comparative tests.
Variable Evaluation Average SD Median Minimum Maximum N p
Diameter of the pelvis of the right kidney First 6.87 1.39 7 5 10 62 0.001
Last 8.40 3.76 7.9 3 23.6 62
Diameter of the pelvis of the left kidney First 7.16 1.56 7.1 5 10 62 o0.001
Last 9.59 4.84 9.2 2.2 23 62
Gestational age (completed weeks) First 22.74 2.70 22 19 30 62
Last 35.95 2.17 36.5 30 40 62
Results of paired Student’s t tests.
Table 3 - Description of the gestational age at diagnosis, initial diameters of the renal pelvis, maternal characteristics (age and
pregnancies), and fetal gender according to the prenatal outcome* and results of statistical tests.
Variable Prenatal outcome Mean SD Median Minimum Maximum N p
GA (weeks) Stability/Regression 23.17 2.54 22.86 19.29 29.14 53 0.901
Progression 23.05 3.31 22.00 20.43 30.14 9
Total 23.15 2.64 22.64 19.29 30.14 62
Diameter of the pelvis of the right kidney (mm) Stability/Regression 6.72 1.33 7 5 9.8 53 0.028
Progression 7.81 1.48 7.8 5 10 9
Total 6.87 1.39 7 5 10 62
Diameter of the pelvis of the left kidney (mm) Stability/Regression 7.03 1.51 7 5 10 53 0.116
Progression 7.91 1.72 8 5 10 9
Total 7.16 1.56 7.1 5 10 62
Maternal age (years) Stability/Regression 28.11 7.29 28 15 44 53 0.999
Progression 28.11 8.05 25 17 44 9
Total 28.11 7.34 27.5 15 44 62
Pregnancies Stability/Regression 2.15 1.43 2 1 7 53 0.438*
Progression 2.44 2.96 1 1 10 9
Total 2.19 1.71 2 1 10 62
Fetal gender (male)N (%) Stability/Regression 40 (75.5) 53 40.999**
Progression 7 (77.8) 9
Total 47 (75.8) 62
Results of Student’s t-tests; * Results of Mann-Whitney tests; ** Results of chi-square tests.
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Based on these findings, we suggest that such cases can be
followed in routine primary prenatal care. Only a final third
trimester scan could be offered at a referral center to inform
postnatal care strategies. Another point to consider is that the
characterization of the natural history of FMBP enables
appropriate counseling of parents facing this fetal diagnosis.
The selection criteria in this series were defined to ensure
that cases with true urinary tract abnormalities were excluded.
Thus, no cases with a RP diameter over 10 mm at 23 w 6 d and
31 w 6 d, as well as no cases with a RP diameter over 15 mm
after 31 w 6 d were included. It is known that these grades
of dilatation correlate well with a worse prognosis in the
postnatal period (13,17,21,38,39).
The criteria used to classify antenatal hydronephrosis are
often different from those used in the present study and are
not uniform in the literature (9-11,40). Many authors define
selection criteria based only on the pelvic diameter without
taking into account the calyceal pattern (5,27,41). For these
reasons, a comparison of the present series with other
literature series is difficult.
To our knowledge the strategy of performing a serial US
in the FMBP cases has not previously been prospectively
assessed in the literature. To assess the cost of performing
serial prenatal USs, Yamamura et al. (13) have concluded,
based on a retrospective series, that a third trimester scan
can be offered after the second trimester diagnosis of FMBP.
This strategy would reduce costs and would not change the
prenatal or perinatal outcomes.
Thus, the data from this study are clinically relevant
because they demonstrate that no prenatal procedures are
needed for FMBP and referral center care, and serial US scans
can be avoided. Our results show that unnecessary over-
booking of referral centers can be avoided to keep prenatal
and childbirth care at low-risk centers in many instances. In
addition, the proposed prenatal follow-up would lower the
costs of prenatal care because only routine US examinations
would be required.
Although the goal of this study was to determine the
prenatal evolution of FMBP, some postnatal results were
obtained. Thirty-two NBs in the cohort were examined based
only on the first postnatal US in the follow-up period. The
NB age at the time of US varied from 4 to 20 days (mean
7.3 days). Twenty-six NBs were in Group 1. Twenty had
normal kidneys, and six showed persistent mild pyelectasis
with no clinical consequences to date. Six NBs were in Group
2, three of whom had no clinical events and three of whom
were followed in the nephro-urologic unit. In this small
neonate group, no discordance was found between the
prenatal classification and postnatal findings.
As a final comment, in this study, sample size estima-
tion was not possible despite the prospective nature of the
study because there are not enough data in the literature.
In future studies, an accurate estimation of sample size could
be obtained based on a 15% estimated rate of cases present-
ing with progressive FMBP. The proposed strategy of per-
forming only one US scan late in the third trimester could be
compared with serial prenatal US in cases of FMBP in a
paired, randomized prospective trial.
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